| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
CASI Pharmaceuticals, Inc.
13G
CASIF · G1933S101
|
11.0% |
11/26/2025
Event 9/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.